✦ LIBER ✦

The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal use

✍ Scribed by Pierre Teillac; Aldo V. Bono; Jacques Irani; Manfred P. Wirth; Alexandre R. Zlotta

Book ID: 116371732
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 758 KB
Volume: 27
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2005.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PARENTERAL MEDROXYPROGESTERONE FOR THE M

PARENTERAL MEDROXYPROGESTERONE FOR THE MANAGEMENT OF LUTEINIZING HORMONE RELEASING HORMONE INDUCED HOT FLASHES IN MEN WITH ADVANCED PROSTATE CANCER

✍ LANGENSTROER, PETER; KRAMER, BRANDON; CUTTING, BRADLEY; AMLING, CHRIS; POULTAN, 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 67 KB

The patient's choice of androgen-depriva

The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy

✍ Claes R. Nyman; Jesper T. Andersen; Per Lodding; Thorsten Sandin; Eberhard Varen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Risedronate prevents early bone loss and

Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer

✍ Pamela Taxel; Robert Dowsett; Lee Richter; Pamela Fall; Alison Klepinger; Peter 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

862 RISEDRONATE PREVENTS EARLY BONE LOSS

862 RISEDRONATE PREVENTS EARLY BONE LOSS AND INCREASED BONE TURNOVER IN THE FIRST 6 MONTHS OF LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY FOR PROSTATE CANCER

✍ Taxel, Pamela; Dowsett, Robert; Richter, Lee; Fall, Pamela; Kleppinger, Alison; 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 94 KB

The Role of Prostate Specific Antigen in

The Role of Prostate Specific Antigen in the Baseline Assessment of Patients undergoing Hormone Therapy for Advanced Prostate Cancer

✍ L. A. EMTAGE; P. W. LEWIS; G. R. P. BLACKLEDGE 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

Picking the Optimal Duration of Hormonal

Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced Prostate Cancer Treated With Radiotherapy

✍ Denham, James W.; Steigler, Allison 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 366 KB